# Curzion Pharmaceuticals, Inc. — Form D

Curzion Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-15. The offering totals $3.5M, of which $3.5M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-07-15
- Form: D
- Accession: 0001782353-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $3.5M
- Investors: 8
- Date of first sale: 2019-03-26
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-344286

## Issuer

- Name: Curzion Pharmaceuticals, Inc.
- CIK: 0001782353
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 12230 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Phone: 619-733-3852

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Mike Grey | Director | San Diego, CA |
| Johan Kordel | Director | San Diego, CA |
| Ed Mathers | Director | TIMONIUM, MD |
| Niall O'Donnell | Director | St. Louis, MO |
| Kyle Rasbach | Director | Boston, MA |
| Susan Dube | Executive Officer | Sandy, UT |
| Mike Grey | Executive Officer | San Diego, CA |

## More

- [CIK 1782353 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1782353&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001782353-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.